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Abstract 
 
Purpose: The purpose of this project was to evaluate outcomes of an existing inpatient 
tobacco cessation counseling program with 30-day follow-up among recently admitted tobacco-
dependent patients who were tobacco-dependent.  
Background/Significance: Tobacco use is considered the number one most preventable 
cause of disease, disability, and death in the United States.  Despite associated dangers, 
approximately 21% Americans currently smoke.  This has led to increased hospital admissions 
and chronic disease management, costing the United States approximately $96 billion per year.  
Decades of research and evidence-based clinical practice guidelines substantiate that inpatient 
tobacco cessation counseling has the potential to improve quit rates post-hospital discharge. 
Method: This quality improvement project utilized existing hospital data containing 
demographic and medical information about patients and tobacco use behaviors.  The goal was 
to answer the question: Does the provision of a tobacco cessation program initiated during 
hospitalization for persons who are tobacco-dependent (a) increase quit attempts or (b) reduce 
tobacco consumption?  The electronic medical record was queried for data related to: 
demographics, insurance type, and diagnosis.  Data related to smoking status and the intervention 
was extracted from a paper chart maintained by the certified tobacco treatment specialist.  
Results: Out of 176 tobacco-dependent patients admitted to the hospital, 100 (57%) 
indicated an intention to quit (at admission time) while only 40 (23%) reported having quit 
within 30 days post discharge (McNemar Test, p=0.000, n=176). The mean number of cigarettes 
smoked per day dropped from 19 cigarettes on admission to 13 cigarettes post discharge. [t 
(158)=6.7476, p=0.000].  
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Conclusions: This quality improvement project showed that although an inpatient 
smoking cessation program did not improve quit rates, it did significantly improve reduction in 
tobacco consumption.  
 
 
 
 
 
Chapter One: Introduction 
 Tobacco cessation counseling in conjunction with the use of nicotine replacement therapy 
and/or tobacco cessation medication has been the standard of care for the treatment of nicotine 
dependence since 2000, when the first clinical practice guideline was published.  Revision to the 
guideline, Treating Tobacco Use and Dependence, was published in 2008 (Fiore et al., 2008).  
Current U.S. policy encourages the implementation of this clinical practice guideline in the 
hospital setting and includes follow-up of patients post discharge.  This chapter will provide an 
overview to the problem of tobacco use, the national policies influencing tobacco cessation 
programs in hospitals, evidence for tobacco cessation counseling interventions, and conclude 
with the clinical problem and purpose of the project.  
Problem of Tobacco Use 
Tobacco use is considered the number one most preventable cause of disease, disability, 
and death in the United States and accounts for more than 435,000 deaths each year (U.S. 
Department of Health and Human Services [USDHHS], 2010).  Despite the dangers associated 
with tobacco use, it is estimated that 20.6% of Americans (46 million) currently smoke 
(Morbidity and Mortality Weekly Report, 2009).  Smoking is a known cause of cancer, heart 
disease, stroke, complications of pregnancy, and chronic obstructive pulmonary disease 
(USDHHS, 2010).  Hospital admissions and management of chronic diseases associated with 
tobacco use costs the U.S. approximately $96 billion per year and another $97 billion in 
productivity loss due to premature deaths (Centers for Disease Control and Prevention [CDC], 
2012). 
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Policy Influences on Tobacco Cessation Initiatives in Hospitals 
 Policies that influence tobacco cessation initiatives in hospitals originate from the Centers 
for Medicare and Medicaid (CMS) and the Joint Commission, and are encouraged by the 
Partnership for Prevention.  The Partnership for Prevention is composed of businesses, nonprofit 
organizations, and government agencies whose mission is to make evidence-based disease 
prevention and health promotion a national priority (Partnership for Prevention, 2011).  The 
Partnership’s Action to Quit (Action to Quit, n.d.) initiative promotes tobacco-use screening and 
tobacco cessation counseling in health care facilities and primary care.  
 CMS implemented disease specific quality measures to evaluate hospital quality of 
patient care in 2001 (CMS, 2011, June 21).  Provision of tobacco cessation counseling was 
identified as a quality measure for tobacco-dependent patients with these diagnoses: acute 
myocardial infarction, stroke, congestive heart failure, and community-acquired pneumonia. 
Compliance with the CMS tobacco cessation quality measure requires that patients with these 
identified conditions receive tobacco cessation counseling during their hospital stay.  In the past, 
CMS has provided financial incentives for hospitals complying with these quality measures. 
However, the Inpatient Prospective Payment System was developed to reimburse hospitals for 
inpatient health care services in which a predetermined rate is set for treatment of specific 
illnesses.  Beginning January 1, 2012, hospitals having high percentages of readmissions within 
thirty days will experience financial penalties.  
The Joint Commission accredits and certifies health care organizations and programs in 
the United States to improve healthcare.  The Joint Commission developed and tested a set of 
comprehensive tobacco cessation performance measures for hospitals.  These measures were 
funded by the Partnership for Prevention and were released for public review on July 1, 2011. 
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Beginning January 1, 2012, the new measures became active; implementation is currently 
voluntary.  The Partnership for Prevention recommended that the new Joint Commission 
inpatient tobacco cessation screening and counseling measures be added to the CMS tobacco 
cessation quality measure and be tied to Inpatient Prospective Payment System (Partnership for 
Prevention, 2011, June 3).  The four Joint Commission tobacco cessation performance measures 
related to hospitalized patients are as follows:  
1. Patients are screened for tobacco use within the past 30 days, during the hospital stay.  
2. Patients receive practical counseling to quit and receive FDA-approved cessation 
medications. 
3. Patients are referred to evidence-based outpatient counseling and should receive a 
prescription for FDA-approved cessation medication upon discharge.  
4. Discharged patients are contacted within 30 days after hospital discharge and follow-
up information regarding tobacco use status is collected.  
Refer to Appendix A for information related to how the performance indicators are measured.   
Tobacco Dependence Counseling 
Tobacco dependence counseling is known as tobacco cessation counseling or smoking 
cessation counseling, and consists of individual, group, and telephone counseling.  Tobacco 
dependence counseling is strongly recommended, along with medication treatment, for patients 
who use tobacco (Fiore et al., 2008).  Refer to Appendix B for a brief overview of the Guideline 
recommendations for clinicians treating tobacco use and dependence (Fiore et al., 2009).  The 
clinical practice guideline defines counseling as a person-to-person (face-to-face) contact 
between a clinician and a patient for the purpose of tobacco use assessment and/or intervention 
(Fiore et al., 2008).  The two components of counseling identified in the guideline are problem 
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solving skills training and social support.  Problem-solving skills include basic information about 
smoking and successful quitting, as well as identification and problem-solving to deal with 
danger situations that increase the risk of smoking or relapse.  Social support strategies include 
encouragement in the quit attempt, communication of caring and concern, and encouraging the 
patient to talk about the quitting process (Fiore et al., 2008). 
 A tobacco cessation intervention may be brief (also referred to as intermediate) or 
intensive.  Brief interventions may last 3 to 10 minutes while intensive interventions last more 
than 10 minutes in duration.  The length or intensity of the intervention is determined by how 
receptive the patient is to the intervention.  The Transtheoretical Model (TTM) of behavior 
change describes the stages of change that are needed to assess behavior modification of 
smoking: precontemplation, contemplation, preparation, action, and maintenance (Prochaska & 
DiClemente, 1983).  In the precontemplation stage, tobacco-dependent patients are not seriously 
considering quitting, which is the defining characteristic of precontemplation.  Moving to the 
contemplation stage, the tobacco-dependent patient is seriously considering a quit attempt within 
the next 6 months, but not within the next 30 days.  Those who are seriously considering quitting 
in the next 6 months and are planning a quit attempt in the next 30 days are in the preparation 
stage (Hartney, 2009).  The 5 A’s model for treating tobacco use and dependence is applied to 
both the brief and intensive counseling intervention (Fiore et al., 2008).  The five components of 
this model are:  
1. Asking about tobacco status at every visit. 
2. Advising patient to quit, in a strong and personalized manner. 
3. Assessing patient willingness to quit.  
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4. Assisting patient to quit by offering medication and counseling and encouraging a 
future quit attempt for patients unwilling to quit. 
5. Arranging follow-up contacts within the first week of the quit date and/or addressing 
willingness to quit at the next visit (for those unwilling to quit at the time). 
The distinquishing characteristics of an intensive counseling intervention includes a 
comphrensive discussion of health risks, addition of sub-specialist referrals, and more frequent 
counseling sessions of longer duration (Fiore et al., 2008).  
Tobacco Treatment Counseling Providers 
Tobacco treatment counseling providers may be trained as a tobacco treatment specialist 
(TTS) or may be a health or allied health care provider with a special interest in tobacco 
cessation counseling.  The Association for the Treatment of Tobacco Use and Dependence 
(ATTUD) defines a TTS as “a professional who possesses the skills, knowledge and training to 
provide effective, evidence-based intervention for tobacco dependence across a range of 
intensities” (ATTUD, n.d., tobacco treatment specialist).  A TTS may work in a variety of 
community settings, including hospitals, and may be a physician, nurse, or an allied health 
provider.  The ATTUD provides standards of practice and competencies used for the training and 
credentialing of TTSs (ATTUD, n.d., core competencies).  Currently, certification is determined 
by individual states versus a national credentialing center.  For example, both the Tobacco 
Dependence Program at the University of Medicine and Dentistry of New Jersey and the Florida 
State University Area Health Education Center (AHEC) Tobacco Program base their TTS 
training curriculum on the guideline and ATTUD Standards for Core Competencies for Tobacco 
Treatment Specialists.  To meet the requirements for certification, applicants must provide proof 
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of completion of an ATTUD approved training program, document work experience in tobacco 
counseling or as a healthcare provider, and pay a registration fee.  
Tobacco cessation counseling intervention in a hospital is not restricted nor required to be 
provided by a certified or ATTUD trained TTS.  No policy has been established by the Joint 
Commission to designate who is authorized to be a tobacco cessation counselor or provider. 
Medicare, however, reimburses for tobacco cessation services that are provided by a physician or 
other Medicare-recognized practitioner who has a Medicare provider number.  These 
professionals include: anesthesiologist assistant, certified nurse midwife, clinical nurse specialist, 
certified registered nurse anesthetist, clinical psychologist, clinical social worker, nurse 
practitioner, physician assistant or registered dietician or nutrition professional (CMS, 2009).  
Each of these professionals are trained in their respective fields but are not required to have 
additional tobacco counseling training.  
Abbreviated Literature Review 
Evidence supports that tobacco dependence interventions can significantly reduce the risk 
of tobacco-related diseases and illnesses, and that health outcomes can be improved (Baumeister 
et al., 2007; Fiore et al., 2008; Rigotti, Munafo, & Stead, 2008; USDHHS, 2010).  Using the 
PICOT format (Melnyk & Fineout-Overholt, 2011), a clinical question was phrased in a manner 
to yield the most relevant information from a litereature search: In tobacco-dependent 
hospitalized patients, does tobacco cessation counseling increase quit rates after discharge? 
PICOT refers to patient population (P), intervention (I), comparison (C), intervention (I), 
outcome (O) and time (T).  Over the past 10 years, three reviews were conducted by Fiore and 
colleagues (1996, 2000, 2008) that included 8,700 studies obtained from 11 electronic databases.  
Subsequent meta-analysis of the randomized controlled trials (RCT) among these studies formed 
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the evidence base for the development of the guideline initiated in 2000 and updated two more 
times through 2008. The guideline underscores that tobacco treatment counseling, in conjunction 
with medication, is the standard of care for persons who are tobacco dependent.  
 There were two systematic reviews conducted since the guideline was published that 
added significant findings to the body of literature.  A review of smoking cessation interventions 
for hospitalized patients was conducted by Rigotti, Munafo and Stead (2008).  Rice and Stead 
(2009) reviewed nursing interventions for smoking cessation.  These were followed by four 
individual studies that provided additional support for smoking cessation interventions for 
hospitalized patients (Smith & Burgess, 2009; De Azevedo et al., 2010; Steinberg, Greenhaus, 
Schmelzer, Richardoson, & Carson, 2011; Joseph et al., 2011).  
 Results of the literature review show that effective tobacco cessation counseling 
interventions for patients must be followed for a minimum of 30 days.  Abstinence can be 
measured by point prevalence, prolonged abstinence, or continuous abstinence.  Point prevalence 
is a measure of cessation based on behavior at a particular point in time, or in a relatively brief 
specified period, such as in 24 hours or 7 days.  Prolonged abstinence typically allows a ‘grace 
period’ following the quit date (usually about two weeks) to allow for lapses/slips during the first 
few days when the effect of treatment may still be emerging, whereas continuous abstinence 
measures cessation involving avoidance of all tobacco use since the quit day until the time the 
assessment is made (Cochrane Collaboration, 2012).  According to Hughes et al. (2003), 
prolonged abstinence (PA) and point prevalence (PP) abstinence are the two most common 
outcome measures in clinical trials of smoking cessation.  In a study to determine if these 
measures produced similar results, Hughes, Carpenter and Naud (2010) found that PA and PP are 
closely related and one can convert PA to PP and vice versa with moderate accuracy.  
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The Problem 
Although tobacco cessation counseling and/or treatment in the hospital has been found to 
be successful in increasing patient quit rates, most hospitals have not made it a priority to 
identify tobacco users, record their status, offer quit assistance during hospitalization, or follow-
up after discharge (Partnership for Prevention, 2011b).  Implementation of the fourth 
performance measure, post-discharge follow-up, may be the most difficult measure to 
implement.  Barriers to post-discharge implementation may include inadequate staffing to 
conduct follow-up, lack of a systematic process to identify patients requiring follow-up, failed 
attempts to contact patients post-discharge, and difficulties with documentation.  The quit 
attempt during hospitalization is often enforced by institutional no-smoking/tobacco use policies, 
which is not initiated by the patient.  The outcome of an in-hospital tobacco cessation counseling 
program is best measured once the patient returns to the home environment.  Providing follow-
up post hospital discharge would re-enforce the counseling initiated in the hospital, provide 
opportunity for recognition of barriers in home or work settings, and suggestions for strategies to 
overcome barriers, measure tobacco abstinence, and maximize success of tobacco abstinence or 
renewed commitment to another quit attempt.  
The performance measures instituted by the Joint Commission, currently voluntary, are a 
step towards holding hospitals accountable for encouraging quit attempts among tobacco-
dependent hospitalized patients.  Consequences of non-compliance with the Joint Commission 
performance may eventually have an economic impact once the measures become mandatory 
and are linked to CMS prospective payment.  Hospitals who readmit patients within 30 days of 
discharge for specified conditions may consequently lose reimbursement for that admission if 
there has not been compliance with established performance measures.  Patients who are likely 
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to be readmitted are those with chronic disease and tobacco dependence (Mohiuddin et al., 
2007).   
Project Purpose 
 The purpose of this project was to evaluate outcomes of an existing inpatient tobacco 
cessation counseling program with 30-day outpatient follow-up among recently admitted persons 
who were tobacco-dependent.  In addition, successful implementation of this project would 
insure compliance with the fourth Joint Commission Tobacco Measure.  The project question 
was:  Does the provision of a tobacco cessation program initiated during hospitalization for 
persons who are tobacco-dependent (a) increase quit attempts or (b) reduce tobacco 
consumption.  
Definition of Terms 
Abstinence 
A period of being quit, i.e. stopping the use of cigarettes or other tobacco products 
(Cochrane Collaboration, 2012). 
Bupropion 
A pharmaceutical drug originally developed as an antidepressant, but now also licensed 
for smoking cessation; trade names Zyban, Wellbutrin (when prescribed as an antidepressant)  
(Cochrane Collaboration, 2012). 
Brief (Low Intensity) Counseling 
Refers to interventions that involve contact between clinicians and patients that last 
between 3 and 10 minutes.  If the length of contact is unavailable, it is coded based on the 
description of content of the clinical intervention (Fiore et al., 2008). 
Cessation 
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Also called quitting.  The goal of treatment is to help people achieve abstinence from 
smoking or other tobacco use; also used to describe the process of changing the behavior 
(Cochrane Collaboration, 2012). 
Cigarette (Smoking) Reduction 
An approach to reducing tobacco toxic exposure by reduction in the number of cigarettes 
or amount of smoking by a significant amount, i.e. 50% (Hatsukami et al., 2005). 
Continuous Abstinence 
A measure of cessation, often used in clinical trials involving avoidance of all tobacco 
use since the quit day until the time the assessment is made (Cochrane Collaboration, 2012). 
Craving 
A very intense urge or desire [to smoke] (Cochrane Collaboration, 2012). 
Cut Down to Quit 
Refers to a use of nicotine replacement therapy as a way to cut down rather than a 
complete replacement of nicotine from tobacco.  It can also be known as ‘reduce to stop’ (Wang 
et al., 2008).  
Intensive (Higher Intensity) Counseling 
Refers to interventions that involve extended contact between clinicians and patients.  It 
is coded based on the length of contact between clinicians and patients (greater than 10 minutes). 
If time spent is not known, it is coded based on the content of the contact between clinicians and 
patients (Fiore et al., 2008). 
Lapse/Slip 
Terms sometimes used for a return to tobacco use after a period of abstinence.  A lapse or 
slip may be defined as a puff or two from a cigarette.  This may proceed to relapse, or abstinence 
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may be regained.  Some definitions of continuous sustained or prolonged abstinence require 
complete abstinence, but some allow a limited number or duration of slips.  People who lapse are 
very likely to relapse, but some treatments may have their effect by helping people recover from 
a relapse (Cochrane Collaboration, 2012). 
Motivational Interviewing 
A directive and patient-centered counseling method used to increase motivation and 
facilitate change (Fiore et al.). 
Nicotine Replacement Therapy (NRT) 
A smoking cessation treatment in which nicotine from tobacco is replaced for a limited 
period by pharmaceutical nicotine.  This reduces the craving and withdrawal experienced during 
the initial period of abstinence while users are learning to be tobacco-free.  The nicotine dose can 
be taken through the skin, using patches, by inhaling a spray, or by mouth using gum or lozenges 
(The Cochrane Collaboration, 2012). 
Pharmacotherapy 
A treatment using pharmaceutical drugs, e.g. NRT, Bupropion, Varenicline (Cochrane 
Collaboration, 2012). 
Point Prevalence Abstinence 
A measure of cessation based on behavior at a particular point in time, or in a relatively 
brief specified period, e.g. 24 hours or 7 days.  It may include a mixture of recent and long term 
quitters (Cochrane Collaboration, 2012). 
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Prolonged Abstinence 
A measure of abstinence that typically allows a ‘grace period’ following the quit date 
(usually about two weeks) to allow for lapses/slips during the first few days when the effect of 
treatment may still be emerging (Cochrane Collaboration, 2012). 
Quit Attempt 
A planned attempt to quit smoking (Fiore et al., 2008).  
Quit Day 
“The day of a given cessation attempt during which a patient tries to abstain totally from 
tobacco use (Fiore et al., 2008, p. 187).” The quit day also refers to when a patient commits to 
quit tobacco use on a specified day after a motivational intervention.   
Quit Smoking Now 
The Quit Smoking Now curriculum is a six week class to assist with the quit attempt 
(Northeast Florida AHEC Network, 2011).  The class is facilitated by a TTS and each class lasts 
approximately one hour.  Each participant receives a workbook to keep.  The six classes are 
titled: 
1. Tobacco: Friend or Foe? 
2. Managing Addiction 
3. Let’s Quit Now! 
4. Develop a Plan for Life – Without Tobacco! 
5. Relapse Prevention 
6. Congratulations. Now Stay the Course! 
Relapse 
A return to regular smoking after a period of abstinence (Cochrane Collaboration, 2012). 
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Tapering 
A gradual decrease in dose at the end of treatment as an alternate to abruptly stopping 
treatment (Cochrane Collaboration, 2012). 
Tobacco Cessation Counseling (Practical Counseling) 
Refers to a tobacco use treatment in which tobacco users are trained to identify and cope 
with events or problems that increase the likelihood of their tobacco use.  For example, quitters 
might be trained to anticipate stressful events and to use coping skills, such as distraction or deep 
breathing, to cope with an urge to smoke.  Relapse interventions are coping skill training, relapse 
prevention, and stress management (Fiore et al., 2008).  
Tobacco Dependence 
Dependence on any forms of tobacco, including but not exclusive to cigarettes, pipes, 
cigars, and chewing tobacco (Fiore et al., 2008).  
Tobacco Treatment Specialist 
“A professional who possesses the skills, knowledge and training to provide effective, 
evidence-based interventions for tobacco dependence across a range of intensities” (ATTUD, 
n.d., tobacco treatment specialist, para. 2).  
Varenicline: Non-Nicotine  
FDA-approved smoking cessation medication.  Its mechanism of action is thought to be a 
function of its ability to serve both as a partial nicotine receptor agonist and a nicotine receptor 
antagonist.  It is available by prescription only.  Trade name is Chantix (Fiore et al., 2008). 
 Withdrawal Symptoms 
“A variety of unpleasant symptoms (e.g., difficulty concentrating, irritability, anxiety, 
anger, depressed mood, sleep disturbance, and craving) that occur after use of an addictive drug 
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is reduced or stopped.  Withdrawal symptoms are thought to increase the risk for relapse” 
(Cochrane Collaboration, 2012; Fiore et al., 2008, p. 193).  
Summary 
Chapter One introduced the problems associated with tobacco use and dependence, and 
described the policies that influence hospital tobacco programs.  Tobacco cessation interventions 
and providers were defined and follow-up within 30 days after discharge was supported by the 
evidence found in the literature.  The significance of this project is that it will build on an 
existing in-hospital tobacco cessation counseling program provided by a certified tobacco 
treatment specialist applied in the “real world.”  The clinical significance for tobacco-dependent 
patients is that it would reinforce their in-hospital quit attempt and focus on supports needed in 
the home/work environments to potentially improve health outcomes and decrease post-
discharge readmission rates. 
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Chapter Two: Review of Literature 
A review of the research evidence and evaluation of existing clinical practice guidelines 
was completed to identify how tobacco cessation counseling affects quit rates among 
hospitalized patients.  This chapter will describe the literature search process, the process used to 
evaluate the clinical practice guidelines, and discuss systematic reviews and individual studies.  
A critical appraisal of the literature will also be provided.  
Sources and Search Process 
 A literature search was conducted using Cochrane Library, Cumulative Index of Nursing 
and Allied Health Literature (CINAHL), and MEDLINE databases for high level evidence using 
the following combination of key terms: tobacco cessation counseling, smoking cessation 
counseling, hospitalized patients, quit rate(s), abstinence, outcomes, clinical outcomes, follow-
up, and discharge follow-up.  Articles dating back to 2007 that had two of the key terms were 
reviewed.  Internet websites for ATTUD and USHHS were reviewed for policy information and 
practice guidelines.  Approximately 163 research articles were found and then narrowed to 8 
based on the strength of the evidence, their relevance to the treatment of tobacco use and 
dependence, and the treatment of hospitalized tobacco-dependent patients. 
Evaluation of the Clinical Practice Guideline 
 The clinical practice guideline, Treating Tobacco Use and Dependence: 2008 Update 
(Fiore et al., 2008), was evaluated using the Appraisal of Guidelines for Research and Evaluation 
II (AGREE) criteria (Brouwers et al., 2010).  AGREE provides a framework to assess the quality 
of a guideline and determine applicability to practice using an objective method of evaluation.  
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The AGREE tool criteria consist of 23 questions and are organized into 6 domains: scope and 
purpose, stakeholder involvement, rigor of development, clarity of presentation, applicability, 
and editorial independence. 
Scope and Purpose 
The need for the guideline was clearly stated.  Need was based on multiple factors, which 
included tobacco use prevalence, tobacco use related morbidity and mortality, the economic 
burden imposed by tobacco use, variation in clinical practice, availability of methods for 
improvement of care, and availability of data on which to base recommendations for care.  The 
stated clinician audience for the guideline is professionals who provide healthcare to tobacco 
users (Fiore et al., 2008).  
Stakeholder Involvement 
The group responsible for the development of the guideline included members of a 
consortium of organizations and individuals who were committed to the treatment of tobacco use 
and dependence, and dedicated to improving U.S. public health.  It was a partnership among 
Federal Government agencies and nonprofit organizations.  Those represented included: Agency 
for Healthcare Research and Quality; Centers for Disease Control and Prevention; National 
Cancer Institute; National Heart, Lung, and Blood Institute; National Institute on Drug Abuse; 
Robert Wood Johnson Foundation; American Legacy Foundation; and University of Wisconsin 
School of Medicine and Public Health’s Center for Tobacco Research and Intervention (Fiore et 
al., 2008).  
Rigor of Development 
The guideline was developed as a result of multiple meta-analyses of the available 
scientific literature published between 1975 and 2007.  The panel of experts identified 
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randomized placebo/comparison controlled trials that met the inclusion criteria and formed the 
body of evidence upon which the guideline is based.  The result of this review of the scientific 
literature is ten guideline recommendations for clinicians (see Appendix B).  The method used 
for the development of the recommendations was clearly described.  The individual studies have 
strength of evidence that provided a relationship between the recommendation and the 
supporting evidence.  The components of tobacco dependence treatment were divided into seven 
chapters.  Within the chapters, tables provided the supporting evidence for the recommendation.  
 External review of the guideline was supplied in written comments by 81 invited 
reviewers and 15 members of the public which included clinicians, healthcare administrators, 
social workers, counselors, health educators, researchers, consumers, key personnel at selected 
Federal agencies, and State tobacco control programs.  The criteria for evaluation of the 
guideline were based on five criteria: validity, reliability, clarity, clinical applicability, and utility 
(Fiore et al., 2008).  Two individuals made oral presentations to the guideline panel during an 
invited open presentation period.  Financial disclosure statements of the reviewers were 
provided.  
Clarity of Presentation 
The guideline recommendations for practice are specific and based on a goal that 
clinicians recommend the use of effective tobacco dependence counseling and medication 
treatments to patients who use tobacco.  Healthcare systems, insurers, and purchasers are 
encouraged to assist clinicians in making effective treatments available.  The ten key guideline 
recommendations are clear and concise.  The easy-to-read tables provide the supporting evidence 
for each recommendation, making it easy for the clinician/user to apply the guideline to his or 
her clinical practice.   
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Applicability 
Facilitators and barriers to clinical practice were described within each recommendation 
as it was discussed in the guideline.  Topics that required additional research were provided at 
the end of each chapter.  Areas requiring additional research for hospitalized patients were 
identified: effectiveness of interventions provided by different hospital personnel, including 
nurses and respiratory therapists; effectiveness of counseling and medications with hospitalized 
patients; and relapse prevention once the patient leaves the hospital, including use of fax-to-quit 
programs (Fiore et al., 2008).  These topics were included in the guidelines, but are frequently 
identified as barriers that need to be addressed.   
Editorial Independence 
This guideline provides a comprehensive list of effective treatment strategies for tobacco 
use and dependence.  The recommendations are appropriate for use by clinicians who practice in 
hospitals.  The strengths of the guideline are objectively identified using the AGREE II tool.  
 All domains of the AGREE II tool resulted in a perfect score except for applicability.  
The reason for a less than perfect score in applicability related to the lack of research related to 
hospitalized patients.  This highlights the need for the evaluation of a tobacco cessation program 
within a hospital and the effectiveness of tobacco cessation counseling is provided by a nurse 
who has been trained and/or certified as a tobacco treatment specialist. 
Systematic Reviews 
 Two systematic reviews of tobacco cessation studies were published after the guideline 
was disseminated.  One review examined tobacco cessation efforts among hospitalized patients 
and the second review focused on the tobacco cessation interventions performed by nurses.  Both 
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reviews indicate that hospital tobacco cessation programs have positive effects on patient quit 
attempts and sustained abstinence.  
 Rigotti, Munafo, and Stead (2008) conducted a systematic review of thirty-three trials 
including randomized controlled trials and quasi-randomized trials of patients who were 
hospitalized.  Patients included in these trials were currently smoking, or had recently quit and/or 
those who planned to quit smoking after discharge.  This study found that intensive counseling 
interventions begun during hospitalization and continued supportive contacts for one month after 
discharge increased smoking cessation rates after discharge.  Further, tobacco programs are 
effective when they are administered to all hospitalized smokers, regardless of admitting 
diagnosis.  In this review, there was one trial of intensive intervention including counseling and 
pharmacotherapy for smokers admitted with cardiovascular disease (Mohiuddin et al., 2007). 
Over a two year follow-up period, there were significant reductions in all-cause mortality and 
hospital readmission rates.  This project reinforces follow-up after discharge to improve quality 
as well as clinical outcomes. 
 In 2009, Rice and Stead conducted a systematic review to determine the effectiveness of 
nursing-delivered smoking cessation interventions.  When reviewers compared a nursing 
intervention to a control or usual care, 31 of the 42 studies found the smoking cessation 
intervention to significantly increase the likelihood of quitting.  Since the largest healthcare 
workforce is comprised of nurses, the authors sought to determine the benefits of smoking 
cessation advice and/or counseling given by nurses to patients.  Although there is the potential 
for an effective intervention, the evidence was weaker when the interventions were brief and 
provided by nurses whose main role is not health promotion or smoking cessation.  This adds 
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strength to the role of a tobacco treatment specialist who has the skills and training to provide an 
opportunity for treatment that includes reinforcement, follow up, and possibly medication.  
Individual Studies 
 Smith and Burgess (2009) conducted a RCT of a smoking cessation intervention initiated 
during a hospital stay of patients who were diagnosed with coronary artery disease.  Two 
hundred seventy-six sequential patients admitted with acute myocardial infarction (AMI) and/or 
coronary artery bypass graft (CABG) were randomly assigned to intensive or minimal smoking 
cessation interventions.  Continuous 12-month abstinence was 57% in the intensive group and 
39% in the minimal smoking intervention group (p < 0.01).  Abstinence was also significantly 
higher among patients admitted for CABG than those admitted with AMI.  The results of this 
project provides additional evidence for targeting patients by diagnosis and suggests that 
hospitalized patients may be more receptive or “ready” to accept tobacco cessation interventions 
during serious health events.  
 Studies emphasize that extending smoking cessation programs post-hospitalization 
improves smoking abstinence.  One randomized controlled trial found that smoking cessation 
rates were 44.9% for individuals receiving a high intensity intervention, 41.7% for individuals 
receiving a low intensity intervention, and 26.3% for individuals receiving usual care (p < 0.03) 
(DeAzevedo et al., 2010).  High intensity care consisted of a 30-minute counseling session by a 
trained counselor who performed a motivational interview.  Low intensity care consisted of a 15-
minute counseling session by a trained counselor advising the patient to stop smoking.  Usual 
care patients were discharged without counseling since tobacco assessment and counseling was 
not the standard practice of the hospital.  None of the patients received smoking cessation 
pharmacotherapy during hospitalization or at discharge.  The program was conducted during an 
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8-month period and patient results were reported at 6 months.  Similarly, Steinberg and 
colleagues (2011) reported that 40% of patients who used post-discharge behavioral treatment 
had significantly higher rates of tobacco abstinence than those who did not participate in a post 
discharge program (53.1% versus 8.5%, p < 0.01).  Meanwhile, Joseph and colleagues (2011) 
compared an eight-week, or usual care (UC), post hospital tobacco intervention of telephone 
follow-up and mailed nicotine replacement therapy to a long-term tobacco intervention for 48 
weeks.  Longitudinal care (LC) counseling targeted repeated quit attempts and smoking 
reduction for those who relapsed.  After 18 months, 30.2% of the LC participants reported 
tobacco abstinence for six months compared to only 23.5% of participants in the UC group. 
Additionally, predictors of abstinence at 18 months were the number of baseline cigarettes 
smoked per day and smoking in the first 14 to 21 day interval post discharge.  The LC 
participants who did not quit smoking reduced the number of cigarettes smoked compared to the 
UC group at 12 months, p < 0.03.  
These individual studies emphasize the importance of post-discharge follow-up and 
continued intervention.  Joseph et al. (2011) identified the 14
th
 to 21
st
 day post discharge as a 
predictor for eventual abstinence and provides evidence that post discharge follow-up programs 
need to minimally target interventions during the first four weeks post discharge.  Also, studies 
conducted after the publication of the guideline cite the use of the combination of brief or 
intensive counseling with medication management to improve quit rates. 
Strength of the Evidence 
The purpose of the literature review was to appraise the evidence related to quit attempts 
and tobacco abstinence among hospitalized patients as a result of tobacco cessation counseling 
intervention.  The body of evidence is extensive, spans over three decades, and has been 
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consistently and systematically reviewed.  It includes one evidence-based clinical guideline that 
is based on meta-analyses of three systematic reviews of randomized controlled trials and two 
systematic reviews.  A systematic review (SR) is a compilation of like studies to address a 
specific clinical question using a comprehensive search strategy and rigorous appraisal for 
summarizing, appraising, and communicating the results and implications of all the research 
available.  It is the most rigorous approach to minimization of bias in summarizing research and 
is considered to be the strongest level (Level I) of evidence (Melnyk & Fineout-Overholt, 2011). 
The four individual randomized controlled trials are considered to be Level II evidence, which is 
“evidence generated from at least one well-designed randomized clinical trial” (Melnyk & 
Fineout-Overholt, 2011, p. 188).  
Conclusion 
 The strength for application of the evidence from meta-analyses of RCTs, systematic 
reviews, and individual RCTs shows that tobacco cessation counseling with follow up within 30 
days after discharge increases quit rates.  Based on findings in this literature review, 
interventions provided by someone whose main role is health promotion and/or tobacco 
cessation is more effective for increasing quit rates. 
The findings in this literature review strongly support the purpose of this project: 
evaluating outcomes of an existing inpatient tobacco cessation counseling program with 30-day 
outpatient follow-up among hospitalized persons who were tobacco-dependent.  The literature 
also provides support for the fourth Joint Commission performance measure: Tobacco users 
should receive at least one follow-up contact within 30 days of hospital discharge to assess 
tobacco use status and to offer support and encouragement to increase quit attempt success for 
sustained abstinence (Joint Commission, 2011, August 8.)  
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Chapter 3: Methodology 
This chapter will describe the project design, data source, sample, data collection, 
measures, and data analysis.  Feasibility of this project and protection of human subjects will 
also be described.  The project will answer the question: Does provision of a tobacco cessation 
program initiated during hospitalization for persons who are tobacco-dependent (a) increase quit 
attempts or (b) reduce tobacco consumption.   
Project Design, Sample, and Data Collection 
 A descriptive design using existing hospital data containing demographic and medical 
information about patients and tobacco use behaviors was used in this project.  Data was 
collected from patients admitted to a rural 48-bed full-service hospital accredited by the Joint 
Commission between January 1, 2012 and April 30, 2012.  The sample consisted of adults (over 
18 years of age) who self-identified using tobacco products upon admission to the hospital.  Data 
was collected by hospital staff and recorded in the patient electronic medical record (EMR) and 
in a paper chart managed by a certified tobacco treatment specialist (CTTS).  Upon admission, 
patients were asked about their tobacco use, specifically if they smoked cigarettes anytime 
during the past 12 months prior to hospital arrival or if they used other tobacco products.  
Patients who were tobacco-dependent were referred to the CTTS.  The CTTS visited the patient 
within 24-48 hours of admission.  Data collected by the CTTS was documented in the EMR and 
paper record of the patient intervention was provided.  Refer to Figure 1 for the patient path 
through the admission, hospitalization, and post-discharge process in the tobacco treatment 
program.    
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Screening - Admission    Intervention - Hospital Stay  Intervention - Discharge  Post Discharge Follow 
 
Figure 1.  The Patient’s Path through the Tobacco Treatment Program: Admission through Follow-up after Discharge.   
Adapted from “Helping patients quit: Implementing the Joint Commission tobacco measure set in your hospital,” by the Partnership 
for Prevention, 2011, Washington, DC: Partnership for Prevention. 
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Measures 
Descriptive Variables 
Patient demographic data included age in years, gender, admitting diagnosis, type of 
health insurance, and type of tobacco products used.  Age (in years) and gender (male or female) 
helped to describe the population sample.  Admitting diagnosis distinguished among congestive 
heart failure, chronic obstructive pulmonary disease, myocardial infarction, pneumonia, any 
surgical diagnosis, and any other medical diagnosis.  This categorization for diagnosis is used by 
CMS (2011, October 4) to establish priority diagnoses for tobacco cessation counseling. 
Insurance type was categorized as none, private, Medicare, Medicaid, other private/public, and 
unknown.  Access to insurance coverage is an enabling factor that has ramifications for patient 
ability to obtain nicotine replacement or medications post discharge.  Patients identified the type 
of tobacco product they used and were asked about the number consumed per day of the type of 
product used.  Types of products included cigarettes, cigars, pipe, and cans/pouches of dip/chew. 
Treatment measures related to the tobacco cessation counseling intervention performed 
by the CTTS included type of visit conducted in the hospital, number of visits, and post 
discharge contact within 30 days of hospital discharge.  The intervention was provided according 
to the conceptually driven evidence-based 5 A’s model for treating tobacco use and dependence 
described in detail in Appendix C.  The TCC contact was coded by type of intervention provided 
(none, brief, or intensive).  A brief intervention is defined as lasting between 3 and 10 minutes, 
while an intensive intervention lasts 10 or more minutes per the clinical practice guidelines.  All 
tobacco-dependent patients received at least one brief intervention from the CTTS while in 
hospital.  Patients were contacted by telephone one to two weeks post discharge through the 30
th
 
day as needed to complete the follow-up.  A successful telephone contact occurred when the call 
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resulted in a conversation with the patient.  An unsuccessful telephone contact was recorded 
when the number reached was not correct, no one answered, or the patient did not respond to a 
message left on an answering machine.  During the phone call, patients were asked about their 
quit attempt and about the types and number of type of tobacco products used since the time of 
their discharge from hospital.  The number of post discharge Quit Smoking Now (QSN) classes 
attended were also recorded by the CTTS who conducted the classes.  
Outcome Variables 
The outcomes of interest in the project were quit attempt, measured categorically as “yes” 
or “no,” and the number of tobacco products, by type, consumed daily.  Hospitalization 
precipitates an involuntary quit for patients.  At admission, quit attempt was measured by asking 
patients whether or not they intended to quit using tobacco products after discharge (“yes” or 
“no”).  Post discharge, quit attempt was measured by asking patients whether or not they had 
stopped using tobacco products since their discharge (“yes” or “no”).  Patients who responded 
“no,” that they did not quit, were asked about the number and type of tobacco products used.  
Respondents who did not quit were given a reminder of the services available in the community 
to help them quit, which includes the Quit Smoking Now classes available at the hospital.  Quit 
attempt was coded as a “no” response when the patient answered “no,” “not sure,” or were 
unable to be contacted/lost to follow-up.  This coding is consistent with what is reported in the 
literature (NAQC, 2009).  A list of variables and their coding is displayed in Table 1.  
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Table 1   
Variables Used for Project and Their Coding 
Descriptive Variables (Participants) Coding 
Age in years 0-99 years 
Gender 1=male 
2-female 
Diagnosis 1 Congestive heart failure 
2 Chronic obstructive pulmonary disease 
3 Myocardial infarction 
4 Pneumonia 
5 Any surgical 
6 Any medical 
Insurance type 1 None 
2 Private 
3 Medicare 
4 Medicaid 
5 Other  
6 Unknown 
Type tobacco used:  cigarettes 0=no, 1=yes 
Type tobacco used:  cigars 0=no, 1=yes 
Type tobacco used:  dip / chew 0=no, 1=yes 
Type tobacco used : other (pipe)  0=no, 1=yes 
  
Intervention Measures(Treatment)  
Type of tobacco cessation counselor contact 0=none 
1=brief 
2=intensive 
Total number TCC contacts 0-99 contacts 
Quit smoking now (QSN) classes 0-6 sessions 
Post-discharge successful telephone contact 0=no, 1=yes 
  
Outcome Measures (Tobacco Use)  
Quit attempt intention at admission 0=no, 1=yes 
Quit  post discharge from hospital 0=no, 1=yes 
  
Number cigarettes smoked per day, at admission 0-99 
Number cigarettes smoked per day, after discharge 0-99 
Number cigars smoked per day, at admission 0-99 
Number cigars smoked per day, after discharge 0-99 
Number daily tobacco use:  dip/chew, at admission 0-99 
Number daily tobacco use:  dip/chew, after discharge 0-99 
Number pipes smoked per day, at admission 0-99 
Number pipes smoked per day, after discharge 0-99 
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Data Analysis 
Data was extracted from the EMR and tobacco program paper chart and manually entered 
into an Excel file by the CTTS and cleaned by the principal investigator.  Data was analyzed 
using SPSS® statistical software (Version 17.0, 2008).  Categorical variables were described 
using counts and percentages, while continuous variables were described using mean and 
standard deviation.  The McNemar test (MedCalc, 2012), a non-parametric test used to compare 
a dichotomous categorical variable in a dependent population, was used to compare intention to 
quit at admission and actual quit attempt post discharge.  The paired sample t test was used to 
compare means related to number of tobacco products used just prior to admission and post 
discharge.  
Feasibility 
This project was feasible and did not require additional resources.  The tobacco cessation 
program has been implemented in the local hospital since the fall of 2010 with a grant from the 
State of Florida.  The program is integrated into usual hospital care and the data had already been 
collected.  The principal investigator is an employee of the institution and has support of the 
hospital administrator.  
Protection of Human Subjects 
 Institutional Review Board (IRB) approval was received from the University of North 
Florida and the Baptist Health Institutional Review Committee (IRC) prior to starting the project 
(See Appendix D).  Since this project used retrospective de-identified hospital data collected by 
the tobacco cessation program, the risk to patients was considered to be minimal and individual 
patient informed consent was not sought.  
  
29 
 
 
 
Chapter Four: Results 
 This chapter reports results that answer the quality improvement project question: Does 
provision of a tobacco cessation program initiated during hospitalization for persons who are 
tobacco-dependent (a) increase quit attempts or (b) reduce tobacco consumption?  Existing de-
identified data of 176 patients admitted to a local hospital between January 1, 2012 and March 
31, 2012 who were tobacco-dependent and visited by a tobacco treatment specialist were used. 
Results describe the sample, the intervention, and report the project outcomes.  
Project Sample 
 There were 176 tobacco-dependent patients in this project; 43% were male and 57% were 
female (see Table 2).  Participants ranged in age from 18 years of age to 87 years with a mean of 
51 years (SD = 15.67 yrs.) and median of 54 years.  The majority of patients (86%) were 
admitted for medical management while 13.64% were admitted for surgery.  Medicare and 
Medicaid insurance type accounted for 40% of health insurance coverage for patients and private 
insurance with a combination of some other public insurance accounted for 35% of coverage, 
while 25% of the patients had no insurance coverage.  The majority (91%) of the tobacco-
dependent patients smoked cigarettes compared to smoking cigar or pipe or chewing dip.  
Intervention and Post-Discharge Follow-Up 
The TTS visited all patients for brief and/or intensive interventions while they were in 
hospital and referred patients to Quit Smoking Now (QSN) classes.  All patients received at least 
one tobacco cessation counseling intervention session while they were hospitalized (see Table 3) 
even if they stated that they were not interested in quitting.  This allowed the TTS to make sure 
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that patients had appropriate nicotine replacement therapy ordered by their physician while in the 
hospital.  
Table 2 
Description of Project Participants  
 n = 176 % Percent Mean (SD) SD 
Age in years  
18-37 years 
38-57 years 
58-87 years  
 
 
38 
73 
65 
 
 
21.59% 
41.47% 
36.93% 
 
 
51 yrs. 
 
16.67 
Gender 
Male 
Female 
 
 
76 
100 
 
43.18% 
56.82% 
  
Diagnosis 
Congestive heart failure 
Chronic obstructive pulmonary disease  
Pneumonia  
Any Surgical 
Any Medical 
 
 
    6 
  33 
    3 
  24 
110 
 
  3.41% 
18.75% 
1.70% 
13.64% 
62.50% 
  
Insurance type 
None 
Private 
Medicare 
Medicaid 
Other public or private 
 
 
44 
33 
53 
17 
29 
 
25.00% 
18.75% 
30.11% 
9.66% 
16.48% 
  
Type tobacco used 
Cigarettes 
Dip / chew  
Cigars 
Other (pipe) 
 
 
160 
    8 
    7 
    1 
 
90.91% 
4.55% 
3.98% 
0.57% 
  
 
The TTS made 298 in-hospital visits on behalf of these 176 patients with 123 (41%) 
visits classified as brief interventions and 175 (59%) visits classified as intensive interventions. 
The majority of patients (55%) received at least one TTS contact visit in hospital.  Some patients 
received only brief interventions, some received only intensive interventions, and some received 
both brief and intensive interventions.  A majority of patients (75%) did not attend the post 
discharge QSN classes.  
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Table 3 
Tobacco Counseling Intervention Visits in Hospital 
 Patients (n) n (visits) % Percent 
In-hospital Intervention Type  
Brief Intervention 
Intensive Intervention 
 
176 
90 
145 
298 
123 
175 
 
 
41.28% 
58.72% 
Number of in-hospital Visits 
One Visit 
Two Visits 
Three Visits 
Four Visits 
Five Visits 
176 
95 
48 
28 
2 
3 
 
298 
95 
96 
84 
8 
15 
 
53.98% 
27.27% 
15.91% 
1.14% 
1.70% 
 
 
Post discharge patient contact was attempted with 116 (66%) of the 176 patients, between 
the 14
th
 and 30
th
 day post discharge, and completed with 74 (42%) of the hospitalized patients 
(see Table 4).  Most (70) patients were contacted by telephone, while contact was made with 4 
patients at a QSN session.  The remaining 42 patients who were contacted by telephone and for 
which the telephone intervention was not completed were either left a message (38 calls) they 
did not return, did not answer the call (2), or hung up the phone (2).  Of the 60 patients who did 
not receive a follow-up phone call, 41 were not contacted and the reason was not specified, 9 
patients had incorrect phone numbers, 6 were not contacted at patient request, and 4 patients had 
no phone number.  Overall, 102 (57.95%) patients were lost to post hospital discharge follow-up.  
 
 
 
 
 
Table 4 
 
Results of Post Discharge Contact 
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 n=176 % Percent 
Completed Call or QSN class contact 
 
Incomplete – message left on machine 
Incomplete – hang up or no answer 
 
No telephone call attempted 
Wrong number / no number 
Patient requested no contact 
74 
 
38 
4 
 
41 
13 
6 
42.05% 
 
21.59% 
2.28% 
 
23.30% 
7.38% 
3.41% 
 
 
Outcomes 
At discharge, only 40 (23%) patients reported quitting tobacco use compared to 100 
(57%) of the same patients who reported “yes,” that they intended to quit smoking once they 
were discharged.  This change in patients who intended to quit but did not was significant 
(McNemar Test, p = 0.000, n = 176).  Consistent with the interpretation of quit attempts in the 
literature (NAQC, 2009), the 102 (58%) patients who were not contacted post discharge were 
coded as not having quit using tobacco, which may have underestimated quit attempts.  Using 
the sub-sample of patients for whom post discharge data was collected, 34 (46%) of the patients 
reported quitting tobacco use post discharge compared to 52 (70%) of the same patients who 
reported a positive intention to quit smoking at time of admission.  The significant difference 
between intent during admission and actual behavior at discharge is in a negative direction. 
Patients who said they would quit smoking did not do so. (McNemar Test, p = 0.003, n = 74).  
 The second outcome related to the amount of tobacco product used at admission in 
comparison with the number of the same product used at discharge.  Comparison was made only 
for the patients who smoked cigarettes as the number of patients who smoked cigars, pipes, or 
chewed dip was very small.  Of the 159 tobacco-dependent patients who smoked cigarettes, 122 
(77%) reported not quitting smoking.  For these non-quitters, the mean number of cigarettes 
smoked post discharge (M = 13, SD = 12.64) was significantly fewer than the mean number of 
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cigarettes (M = 19, SD = 12.10) smoked at admission [t (158) = 6.7476, p = 0.000].  Again, 
consistent with the literature, patients who were not contacted post discharge were coded as 
using the same number of tobacco products they used at admission.  Consequently, this analysis 
was repeated on the sub-sample of patients (n = 69) who continued to smoke cigarettes and for 
whom post discharge data was collected.  The mean number of cigarettes smoked post discharge 
(M = 7, SD = 10.58) was significantly lower than the mean number of cigarettes (M = 19, SD = 
13.09) smoked at admission [t (68) = 7.5096, p = 0.000].  
Summary 
 The results of this project validate the effectiveness of a tobacco cessation program 
within a hospital setting.  All patients received a minimum of one brief tobacco cessation 
counseling contact.  Although only 23% of smokers had quit, those smokers who continued to 
smoke reduced their cigarette consumption significantly after discharge.  
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Chapter 5: Discussion 
 This chapter will discuss the major findings of the quality improvement project, their 
relationship to the existing research, explore clinical relevance to nursing practice, acknowledge 
limitations, and recommend direction for future research.  The results of this quality 
improvement project demonstrate that an evidence-based inpatient smoking cessation program 
provided by a dedicated hospital nurse with tobacco cessation counseling training is feasible and 
reduces patient tobacco consumption.  
 Current approaches to treating tobacco use and dependence reflect the perspective that 
tobacco dependence is a chronic disease.  Tobacco dependence often requires repeated 
interventions and multiple attempts to quit (Steinberg et al., 2008).  The focus on chronic disease 
management is in direct alignment with one of the key recommendations of the CPG (Fiore et 
al., 2008).  In a randomized control trial, Joseph et al. (2011) found that smoking interventions 
that are based on chronic disease management principles of care are approximately 75% more 
effective at accomplishing long term abstinence than delivery of an isolated episode of care. 
Clinical Relevance 
 In alignment with the Joint Commission Tobacco Measures (Joint Commission, 2011, 
August 8), all patients in this project were screened for tobacco use during their stay, received 
counseling to quit, received FDA-approved cessation medications, and were referred to 
outpatient counseling and offered FDA-approved cessation medication upon discharge.  A 
combination of classes and the use of nicotine replacement therapy to reduce symptoms 
associated with nicotine withdrawal are recommended as the standard for tobacco cessation 
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treatment.  Recently, Rigotti, Clair, Munafo, and Stead (2012) published an update regarding 
interventions that begin during the hospital stay and include at least one month of supportive 
contact after discharge.  A review of fifty trials found that tobacco cessation counseling during a 
hospital stay with follow-up support for at least one month after discharge increases smoking 
cessation.  This confirms and validates the implementation of a hospital program to provide 
tobacco cessation counseling to tobacco-dependent hospitalized patients.  
Application to Nursing Practice 
 At this hospital, the initial assessment of smoking status is collected within the first 24 
hours in the admission assessment completed by the admitting nurse.  This provides information 
for the admitting physician who might not have a complete health history on the patient.  Timely 
notification can result in appropriate administration of tobacco cessation medication for nicotine 
withdrawal symptoms to avoid patient discomfort.  According to Rigotti et al. (2008), nurses are 
in a good position to aggressively assess smoking status and counsel patients on effective 
methods for patients to quit smoking.  However, there are significant barriers to nurses providing 
tobacco cessation counseling.  These include time, knowledge, and comfort level of providing 
counseling.  Competing nursing priorities while caring for unstable or critically ill patients is 
evident, but the greatest barrier for nurses is lack of tobacco cessation knowledge and training. 
This lack of knowledge and training translates to a low comfort level in providing adequate 
counseling to support a quit attempt upon discharge.  Motivational interviewing, which is the 
cornerstone of effective tobacco cessation counseling, not only takes training but also 
considerable practice.  At this facility, there is a registered nurse who is a certified tobacco 
treatment specialist.  This person provides counseling using a chronic disease management 
model that emphasizes short and long term health benefits of quitting tobacco.  Hospitalized 
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patients frequently experience life-threatening events that become highly teachable moments for 
encouraging a quit attempt.  Rigotti (2008) also found that supportive contact for over 1 month 
after discharge increases the odds of smoking cessation by 65% at 6 to 12 months.  Having a 
registered nurse with specialized training providing this support is essential since nurses at the 
bedside cannot follow-up with patients after discharge.  This type of model lends support to all 
healthcare providers for integration of tobacco cessation interventions in their daily practice. 
Physicians at this facility have become more involved in including tobacco cessation into their 
daily rounds by supporting the counseling that is being provided by the TTS.  It also creates an 
opportunity for the multidisciplinary team to provide positive reinforcement of the tobacco 
cessation intervention.  Hearing the same message from the entire team sends a strong message 
to the patient.  
Limitations 
 This project targeted the beginning phase of a tobacco cessation program that is in 
alignment with the Joint Commission tobacco measures within a hospital setting.  A descriptive 
design using existing quantitative hospital data about patients and their behaviors related to 
tobacco use was used in this project.  This convenience sample approach using existing hospital 
data restricts findings that might be validated with a randomized controlled clinical trial design to 
measure the differences in standard care versus interventional care.  
 Quit rates were only evaluated within 30 days post discharge.  Fiore et al. (2008) 
suggested that follow-up should continue for a minimum of 6 months to accurately evaluate the 
effects of tobacco cessation interventions.  In addition, the results are limited by the validity of 
self-report of smoking status versus biochemical validation.  According to Gorber, Schofield-
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Hurwitz, Hardt, Levasseur, and Tremblay (2009), self-reports tend to underestimate their 
smoking status.  
 Implementation of the fourth performance measure, post-discharge follow-up within 30 
days post discharge and follow-up information regarding tobacco use status is collected, proved 
to be the most difficult measure to implement.  One unanticipated barrier included a lack of 
correct contact information for patients.  It was discovered after the project period and during the 
data analysis that a problem existed where updated contact information collected on admission in 
an electronic billing data program was not “flowing over” to the EMR.  This could explain the 
large percentage of patients who were not reached.  Gadomski, Gavett, Krupam Tallman, and 
Jenkins (2011) experienced similar difficulties when using the EMR as a data source and lead to 
missing data.  This has an effect on the variables in the analysis and is present in the real world 
hospital setting.   
Lost to Follow-Up 
In the best of circumstances, follow-up can be difficult; data will always be missing.  
How to handle missing outcome data requires an informed decision while calculating abstinence 
rates.  In reporting outcomes measures for abstinence rates, there are two approaches: Intention-
to-Treat (ITT), where all non-respondents are considered to be smoking; and responder rate 
(RR), which represents/includes only those who respond.  When determining which approach to 
use as an outcomes measure, it is important to understand the limitations of each approach.  In 
the conduct of clinical research, it is assumed that individuals who do not complete a treatment 
or protocol are considered “lost to follow-up” and have worse outcomes than those who 
complete it.  The RR approach ignores the association and leads to a systematic overestimate of 
the true quit rate.  ITT adopts an extreme position that all individuals not completing the follow-
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up evaluation are considered treatment failure, and tends to underestimate the true quit rates 
(NAQC, 2009).  The majority of the population lost to follow-up could underestimate true quit 
rates.  Recognizing the risks of over- and underestimation of quit rates, NAQC recommends an 
approach that most closely approximates the true quit rate.  For the purposes of this project, 
using the responder rate (RR), of the 74 (42%) patients who received follow-up, 34 (46%) 
reported quitting.  Completion of follow-up not only assesses the success rate but in doing so, 
completes the fourth JC tobacco measure.  However, a larger number of responders might have 
improved the quit rate for those who intended to quit.   
 Fiore et al. (2008) found that follow-up contact should begin soon after the quit date, 
preferably during the first week with a second follow-up within the first month.  Findings from 
the 2007 Cochrane Systematic Review (Rigotti et al., 2008) indicated that post-hospitalization 
follow-up is a key component of effective interventions.  The challenges associated with follow-
up post discharge for hospitalized tobacco-dependent patients during implementation of this 
project are documented.  
Future Research 
 Future research should include identifying strategies for increasing patients’ recognition 
of the need for individual counseling and/or social support through group treatment as well as 
use of pharmacotherapy to manage nicotine withdrawal and cravings.  Integrating new forms of 
technology as a training method, such as computer applications and internet technology should 
be considered.  More research is also needed on relapse prevention to identify successful 
strategies that will assist in sustained abstinence. 
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Conclusion 
 Quit attempts dropped from admission to post discharge and there was a significant 
decrease in the amount of cigarettes smoked post discharge compared to number of cigarettes 
smoked prior to admission.  Despite the large number lost to follow-up, more than 23% of the 
total number reported being quit.  Based on the findings from Joseph et al. (2011), this would 
indicate eventual abstinence for those patients receiving tobacco cessation counseling during 
their hospitalization.  
 Twenty-four percent of the project group had an admitting diagnosis of CHF, COPD, 
and/or pneumonia.  When tobacco-dependent patients are admitted to the hospital, evidence-
based disease management is provided in addition to tobacco cessation guidelines.  
Readmissions within 30 days for the patients in this project were less than 2% (3 patients).  This 
is significantly less than the Florida state average 30-day all-cause readmission rate average of 
19.7% and a national average of 18.5% (Florida Medical Quality Assurance Inc. [FMQAI], 
2012).  Providing guidance to managing symptoms associated with chronic disease has been 
shown to be effective in preventing readmissions (Krumholz et al., 2002; Smith & Burgess, 
2009).  For a hospital that treats Medicare patients, this is significant.  The new CMS policy that 
began January 1, 2012, penalizes hospitals having high percentages of preventable readmissions 
within thirty days for all-cause readmissions, as well as readmissions for CHF, COPD, 
Pneumonia, and Acute Myocardial Infarction.  This supports the CMS, Joint Commission and 
the Partnership for Prevention guidelines for developing or using comprehensive tobacco 
cessation strategies to reduce death and disability related to tobacco use.  Rigotti (2012) found 
that intensive counseling interventions are effective when provided to all hospitalized smokers, 
regardless of admitting diagnosis.  The establishment of this tobacco cessation program helps 
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meet our hospital quality and national performance measures, and by reducing of readmissions, 
improves the financial bottom line.  Lastly, by addressing and treating the deadly effects of 
tobacco use, an opportunity exists for improving the quality of life for patients with chronic 
diseases tied to tobacco use.  
 This quality improvement project demonstrated an inpatient smoking cessation program 
conducted by someone whose main role is health promotion and/or tobacco cessation is effective 
for improving outcomes.  Outcomes included a 23% quit rate, a decrease in tobacco 
consumption, and a reduction in readmission rate within 30 days post discharge.  Although the 
primary goals of improving quit rates was not met, reduction in tobacco consumption for those 
unable to quit were met.  Therefore, this quality improvement project established the 
effectiveness at this hospital and has established that outcomes may further improve through the 
use of additional counseling/support following hospital discharge.   
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Appendix A 
The Joint Commission Tobacco Measure Set 
Measure Identification Number Tobacco Measure Set Specifications 
TOB-1 Tobacco Use Screening  Numerator: The number of patients who were 
screened for tobacco use status. 
Denominator: The number of hospitalized inpatients 
18 year of age and older. 
TOB-2 Tobacco Use Treatment 
Provided or Offered  
Numerator: The number of patients who received or 
refused practical counseling to quit and received or 
refused US Food and Drug Administration (FDA) 
approved cessation medications. 
Denominator: The number of hospitalized inpatients 
18 years of age and older identified as current tobacco 
users. 
TOB-2a Tobacco Use Treatment  Numerator: The number of patients who received 
practical counseling to quit and received FDA-
approved treatment cessation medications. 
Denominator: The number of hospitalized inpatients 
18 years of age and older identified as current tobacco 
users. 
TOB-3 Tobacco Use Treatment 
Provided or Offered at Discharge 
Numerator: The number of patients who were referred 
to or refused evidence-based outpatient counseling 
and received or refused a prescription for FDA-
approved cessation medication at discharge. 
Denominator: The number of hospitalized inpatients 
18 years of age and older identified as current tobacco 
users. 
TOB-3a Tobacco Use Treatment at 
Discharge 
Numerator: The number of patients who were referred 
to evidence-based outpatient counseling and received 
a prescription for FDA-approved cessation medication 
at discharge. 
Denominator: The number of hospitalized inpatients 
18 years of age and older identified as current tobacco 
users.  
TOB-4 Tobacco Use: Assessing 
Status after Discharge 
Numerator: The number of discharged patients who 
are contacted within 30 days after hospital discharge 
and follow-up information regarding tobacco use 
status is collected. 
Denominator: The number of hospitalized inpatients 
18 years of age and older identified as current tobacco 
users. 
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Appendix B 
Guideline Recommendations for Clinicians Treating Tobacco Use and Dependence 
 
1. Tobacco dependence is a chronic condition that often requires repeated intervention. However, 
effective treatments exist that can produce long-term or even permanent abstinence. 
2. It is essential that clinicians and health care delivery systems consistently identify and document 
tobacco use status and treat every tobacco user seen in a health care setting.  
3. Tobacco dependence treatments are effective across a broad range of populations. Clinicians should 
encourage every patient willing to make a quit attempt to use the counseling treatments and 
medications recommended in this Guideline. 
4. Brief tobacco dependence treatment is effective. Clinicians should offer every patient who uses 
tobacco at least the brief treatments show to be effective in this Guideline 
5. Individual, group and telephone counseling are effective, and their effectiveness increases with 
treatment intensity. Two components of counseling are especially effective and clinicians should use 
these when counseling patients making a quite attempt: Practical counseling (problem solving/skills 
training) and social support delivered as part of treatment. 
6. Numerous effective medications are available for tobacco dependence, and clinicians should 
encourage their use by all patients attempting to quit smoking – except when medically 
contraindicated or with specific populations for which there is insufficient evidence of effectiveness 
(i.e. pregnant women, smokeless tobacco users, light smokers, and adolescents). Seven first-line 
medications (5 nicotine and 2 non-nicotine) reliably increase long-term smoking abstinence rates: 
Bupropion SR, Nicotine gum, Nicotine inhaler, Nicotine lozenge, Nicotine nasal spray, Nicotine 
patch, and Varenicline. Clinicians also should consider the use of certain combinations of medications 
identified as effective in this Guideline. 
7. Counseling and medication are effective when used by themselves for treatment tobacco dependence. 
The combination of counseling and medication, however, is more effective than either alone. Thus 
clinicians should encourage all individuals making a quit attempt to use both counseling and 
medication. 
8. Telephone Quitline counseling is effective with diverse populations and has broad reach. Therefore, 
clinicians and health care delivery systems should both ensure patient access to Quitline and promote 
Quitline use. 
9. If a tobacco user currently is unwilling to make a quit attempt, clinicians should use the motivational 
treatments shown in this Guideline to be effective in increasing future quit attempts. 
10. Tobacco dependence treatments are both clinically effective and highly cost-effective relative to 
interventions for other clinical disorders. Providing coverage for these treatments increase quit rates. 
Insurers and purchasers should ensure that all insurance plans include the counseling and medication 
identified as effective in this Guideline as covered benefits. 
 
 
 
Fiore, M. C., Jaén, C. R., & Baker, T. B, Bailey, C. W., Benowitz, N. L., Curry, S. J.,…Wewers,  
M. E. (2009). Treating Tobacco Use and Dependence: 2008 Update. Quick Reference Guide for 
Clinicians.  Rockville, MD: US Department of Health and Human Services, Public 
Health Service.  
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Appendix C 
Tobacco Cessation Counseling Intervention Provided by TTS 
 
 Using the 5A’s model as a guide, the TTS visits each patient that has been identified 
through the admission assessment: 
 
Ask/Advise/Assess about tobacco use: 
 
TTS might say 
 “Good morning, do you mind if we talk about smoking? [Asking permission] 
Since you have been admitted, you have not been allowed to smoke. How are you feeling? Are 
you using medication to help with the craving symptoms?  
 
Information provided includes:  If the patient is having symptoms, the orders are reviewed for 
NRT or medications for quitting. Physician is notified to report craving symptoms and/or to 
obtain orders.  If approved by the attending physician, nicotine replacement therapy and/or 
medication are offered throughout the hospital admission to assist with cravings. If NRT or 
medications for symptom relief are contraindicated, other techniques are discussed. Diversion 
tactics that can help deal with cravings are discussed, such as The 4D’s.  They include the 
following:  
Delay – No matter how strong the craving is, convince yourself that you can wait 5 or 10 
minutes.  
Deep Breaths – Deep breathing is a technique than can help you relax and possibly make 
the craving go away.  
Drink Water – Drinking cold water helps cravings go away and helps keep your hands 
and mouth busy.  
Distract – Distract yourself by getting up or making yourself active. In the hospital, 
suggestions such as reading or watching TV may work if the patient is bedridden. If the 
patient is able to get out of bed, making an effort to change their environment, such as 
walking in the hall is suggested. 
 
Once craving symptoms are resolved and/or recognized, using motivational interviewing 
techniques, permission to talk about smoking is again requested with more emphasis on a quit 
attempt. This communicates respect.  
 
Assess/Advise to quit: Motivational interviewing: 
 
TTS might say 
“Do you mind if we talk about your smoking?” 
 “What do you know about the effects of smoking on your health?  
“Do you think smoking has contributed to the reason you were admitted to the hospital?” 
“Would you be interested in learning more about the effects of tobacco smoking on your 
health?” 
 
Information provided includes:  For smokers who are not interested in a quit attempt, tobacco 
cessation counseling from the TTS is brief, typically lasting less than five minutes.  
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Another approach is: 
 “What I hear you saying is that it’s not causing you any problems at this time…what might it 
take for you to quit?” Although a brief advice to quit may not accomplish a quit attempt at 
discharge, the patient has an opportunity to learn valuable information which may lead to a quit 
attempt at a later date.  
 
For those patients who want to consider a quit attempt, using reflective listening,  
the TTS might say, “I get the sense that you want to quit, but you are not sure. What are your 
concerns?” In most cases, this leads to more than a brief intervention. For this unsure patient the 
TTS continues to provide counseling as long as the patient continues to be interested and/or 
continues to ask questions. 
 
Assist in quit attempt: The patient who desires to make a quit attempt/set a quit date. 
 
Information provided includes:  The TTS provides individualized intensive evidence-based 
tobacco cessation  counseling, conducts a more extensive assessment of smoking habits, triggers, 
and coping strategies - and helps the smoker develop a quit plan to increase the chance of a 
successful quit. If approved by the attending physician, nicotine replacement therapy is offered 
throughout the hospital admission to assist with cravings. Planning for discharge, patients are 
offered free nicotine replacement therapy that has been provided through a grant from the State 
of Florida, Department of Health. All patients are referred to Quit Smoking Now classes that are 
offered at the hospital at two different days and times of the week. They are also given 
information regarding other classes within the community and are given the number for the 
Florida Quitline.  
 
Arrange for follow-up:  
 
Information provided includes:  At the end of hospitalization, the TTS provides information for 
continuation of tobacco treatment after hospital discharge. The goal is to link the smoker with 
smoking cessation counseling and resources for NRT/medication after discharge. For those 
patients who are attempting to quit, they are offered free NRT that will last for their first two 
weeks post hospital discharge. In addition, they are referred to free on-site classes that are 
facilitated by the TTS on two different days/times of the week where they can also receive 
additional NRT. Contact information for community-based resources including the State 
telephone Quitline, local programs, websites and a resource tip sheet are provided for all patients 
at discharge, including those hospitalized patients who stated they did not want to quit. The TTS 
informs the patient that she will follow up with them by phone after discharge. The telephone 
number is verified and the TTS states that she will call within the next week. 
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Assess/Advise/Arrange Follow-up after discharge:  
 
Post discharge contact is initiated within the first week after discharge if possible.  The TTS 
phones the patient. At the time of the phone call, the patient is asked for permission to talk with 
them about their quit attempt. If there is no answer, she leaves a message – if she doesn’t hear 
from them she gives another call. If there is no phone number, a post card reminder is sent.  
 
With permission, tobacco status is assessed and cessation support is offered. Tobacco cessation 
support includes: identification of barriers to abstinence in the home and/or work environment, 
reassessment of medications and/or NRT, and motivational support. Those who are abstinent are 
congratulated on their success; however, if tobacco use has occurred, an offer to review the 
circumstances and offer appropriate advice and/or counseling is provided. If the patient has 
relapsed, then problem-solving techniques can be reviewed to assist patients to resume a quit 
attempt. Patients have the opportunity to identify problems they have encountered and challenges 
that they anticipate with continuing their quit attempt. Patients are reminded to refer to their 
tobacco cessation tip sheet. Reminder for QSN classes and quit lines are also prompted.  
 
 
 
 
 
 
46 
 
Appendix D 
IRB Approval Documents 
 
Office of Research and Sponsored Programs 
1 UNF Drive 
Jacksonville, FL 32224-2665 
904-620-2455 FAX 904-620-2457 
Equal Opportunity/Equal Access/Affirmative Action Institution 
 
MEMORANDUM 
 
DATE: April 23, 2012 
TO: Ms. Marion Mann 
VIA: Dr. Barbara Kruger 
Nursing 
FROM: Dr. Katherine Kasten, Chairperson 
On behalf of the UNF Institutional Review Board 
RE: Review of New Submission by the UNF Institutional Review Board 
 IRB# 317125-1: 
“IMPROVING QUIT RATES FOR TOBACCO-DEPENDENT HOSPITALIZED 
PATIENTS” 
 
This is to advise you that your project, “IMPROVING QUIT RATES FOR TOBACCO-
DEPENDENT HOSPITALIZED PATIENTS” was reviewed on behalf of the UNF Institutional 
Review Board. You are receiving this waiver because this project was declared “not research 
involving human subjects” based on the federal definition of research involving human subjects as 
stated in the U.S. Department of Health and Human Services Code of Federal Regulations  46.102. 
Therefore, it is not necessary for this project to be reviewed and approved by the UNF IRB. 
 
Thank you for submitting your work for IRB review. We appreciate that you understand the value of 
IRB review of research and projects conducted at UNF. Any unanticipated problems involving risk 
and any occurrence of serious harm to subjects and others shall be reported promptly to the IRB. This 
waiver should be kept for your records and applies to your project in the form and content as submitted 
to the IRB for review. 
Any variations or modifications to this waived project as related to dealing with human subjects must be 
cleared with the IRB prior to implementing such changes. 
 
Should you have questions regarding your project or any other IRB issues, please contact the research 
integrity unit of the Office of Research and Sponsored Programs by emailing  IRB@unf.edu or calling 
(904) 620-2455. 
 
This letter has been electronically signed in accordance with all applicable regulations, and a copy is 
retained within UNF's records. 
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820 Prudential Drive, Suite 413 
Jacksonville, Florida 32207 
Phone: 904.202.2127 
Fax: 904.202.2331 
ircsubmission@bmcjax.com 
 
Institutional Review Committee 
 
 
MEMORANDUM 
 
 
 
TO: Marion Mann, MSN, RN, CNS-BC, CTTS  
FROM: Michael Joyce, MD, PhD
DATE: June 7, 2012 
 
RE: Expedited Review - Approval 
 
 
 
 
The Institutional Review Committee (IRC) of Baptist Medical Center (BMC) met on June 
6, 2012, and the following amendment was reviewed and approved via 
expedited review: 
 
#10-64, Baptist Health, "Improving Patient, Employee, and Family Health 
Outcomes Through Implementation of a Tobacco Cessation Program". 
-Amendment.  Review existing data under “Improving Quit Rates for Tobacco 
Dependent Hospitalized Patients”. 
 
If you have any questions, please contact the IRC office immediately.  The BMC 
IRC meets the requirements in 21 CFR 56 (Rev.), 45 CFR 46 (Rev.) and ICH (E6) 
GCP guidelines. 
 
 
 
 
Signature Deleted
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